Suggested dosing of Isatis indigota (da qing ye)
No typical dosing guidelines
Many different manufacturers; follow specific mfct suggestions
Suggested uses of Isatis indigota (da qing ye)
acute parotitis, upper respiratory tract infection, encephalitis, hepatitis, lung abscess, psoriasis, dysentery, acute gastroenteritis, prostate cancer, and HIV
Efficacy
There is insufficient evidence to support use for above indications
Isatis indigota (da qing ye) adverse (side) effects
Frequency not defined
N/V
Hematuria
Warnings
Contraindications
Hypersensitivity
Pregnancy and lactation
Pregnancy category: N/A
Lactation: N/A
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of Isatis indigota (da qing ye)
Metabolism: N/A
Excretion: N/A
Mechanism of action
Increased phagocytosis; anti-inflammatory
